Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.2 - $4.2 $440,000 - $840,000
-200,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$2.83 - $8.69 $138,670 - $425,810
49,000 Added 32.45%
200,000 $806,000
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $2.04 Million - $3.67 Million
-246,000 Reduced 61.96%
151,000 $1.26 Million
Q3 2021

Nov 12, 2021

BUY
$9.15 - $13.28 $3.63 Million - $5.27 Million
397,000 New
397,000 $4.6 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $8.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.